Evaluating the indotecan–neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal Emax regressions is a research paper published in Cancer Chemotherapy and Pharmacology (2023). On theSindex it has a DataRank of 0.104. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →NCI
Grant: UM1CA186690
NCI
Grant: U24CA247643
NCI
Grant: N01-CM-2011-00015C
National Center for Institutional Diversity, University of Michigan
Grant: P30CA47904
Intramural NIH HHS
Grant: ZIA BC011078
NCI NIH HHS
Grant: R50 CA211241
NCI NIH HHS
Grant: P30 CA047904
National Institutes of Health
Grant: 5U24CA247643-05
PITT-CAL ETCTN PK Resource Laboratory
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 5UM1CA186690-09
NCI ETCTN Pittsburgh Cancer Consortium (PCC)
FWCI
0.11
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals